Nkarta (NKTX) Receivables - Other (2019 - 2026)
Nkarta (NKTX) posted quarterly Receivables - Other of $1.7 million for Q1 2026, down 29.17% year-over-year from $2.4 million in Q1 2025, and down 15.0% quarter-over-quarter from $2.0 million in Q4 2025.
Nkarta (NKTX) Receivables - Other (2019 - 2026) Analysis & Trends
Nkarta's Receivables - Other history runs 8 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Receivables - Other fell 29.17% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 29.17% YoY), while the FY2025 annual figure was $2.0 million, down 20.0% from the prior year.
- Receivables - Other for Q1 2026 stood at $1.7 million, down from $2.0 million in the prior quarter.
- The five-year high for Receivables - Other was $2.5 million in Q3 2024, with the low at $600000.0 in Q1 2023.
- The 5-year median for Receivables - Other is $1.3 million (2022), against an average of $1.6 million.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other tumbled 40.0% in 2023, then soared 177.78% in 2024.
- Nkarta's Receivables - Other stood at $800000.0 in 2022, then jumped by 50.0% to $1.2 million in 2023, then jumped by 108.33% to $2.5 million in 2024, then slipped by 20.0% to $2.0 million in 2025, then fell by 15.0% to $1.7 million in 2026.
- Business Quant data shows NKTX's Receivables - Other at $1.7 million in Q1 2026, $2.0 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Mn |
| Jun 30, 2026 | 2.10 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |